These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32535598)

  • 21. Management of AL amyloidosis in 2020.
    Palladini G; Milani P; Merlini G
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):363-371. PubMed ID: 33275753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibril-directed Therapies in Systemic Light Chain AL Amyloidosis.
    Bhutani D; Leng S; Lentzsch S
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):555-559. PubMed ID: 31262668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
    Ablasser K; Verheyen N; Glantschnig T; Agnetti G; Rainer PP
    Curr Med Chem; 2019; 26(16):2865-2878. PubMed ID: 29303069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of systemic amyloid diseases.
    Obici L; Perfetti V; Palladini G; Moratti R; Merlini G
    Biochim Biophys Acta; 2005 Nov; 1753(1):11-22. PubMed ID: 16198646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prevalence and Management of Systemic Amyloidosis in Western Countries.
    Nienhuis HL; Bijzet J; Hazenberg BP
    Kidney Dis (Basel); 2016 Apr; 2(1):10-9. PubMed ID: 27536687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM
    Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid heart disease: a brief review of treatment options.
    Dubrey SW
    Postgrad Med J; 2012 Dec; 88(1046):700-5. PubMed ID: 22745180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Care of Patients with Cardiac Amyloidosis.
    Itzhaki Ben Zadok O; Kornowski R
    Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the management of AL Amyloidosis.
    Kastritis E; Dimopoulos MA
    Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
    Hasib Sidiqi M; Gertz MA
    Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic amyloidosis: novel therapies and role of biomarkers.
    Nuvolone M; Merlini G
    Nephrol Dial Transplant; 2017 May; 32(5):770-780. PubMed ID: 27540044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal amyloidosis].
    Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
    Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirming the Diagnosis of Amyloidosis.
    Wisniowski B; Wechalekar A
    Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional Therapy for Amyloid Light-Chain Amyloidosis.
    Milani P; Palladini G
    Acta Haematol; 2020; 143(4):365-372. PubMed ID: 32353854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in the diagnosis and treatment of cardiac amyloidosis].
    Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G
    Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.